BEL 20 Slips to 3-Month Low as Healthcare and Consumer Stocks Drag

Belgium's benchmark stock index, the BEL 20, ended Friday's session nearly flat, inching down by 0.05% to close at a new three-month low. The slight decline was primarily driven by losses in the healthcare and consumer-focused sectors, according to market data.

Session in Review

The narrow loss for the headline index reflected broader negative sentiment on the Brussels Stock Exchange, where falling stocks outnumbered advancing ones by a margin of 48 to 41, with 12 issues ending the day unchanged. Sector-specific weakness in Healthcare, Consumer Goods, and Beverages was the primary driver behind the index's negative performance.

Index Leaders and Laggards

Biopharmaceutical company argenx SE (EBR:ARGX) was the session's most significant decliner among blue-chip stocks, with its shares falling 3.11% to trade at 815.40 at the close. Other notable underperformers included:

Ad

• Aperam SA (AS:APAM), which declined 2.37%.
• Aedifica (EBR:AOO), which was down 1.45%.

Providing a counterbalance, materials technology group Umicore SA (EBR:UMI) led the gainers, surging 3.02% to end the day at 21.18. It was joined by semiconductor firm Melexis NV (EBR:MLXS), which added 2.06%, and investment company Sofina (EBR:SOF), which rose 1.67%.

Broader Market Context

In commodity markets, both crude oil and gold futures traded lower during the session. West Texas Intermediate crude for November delivery fell over 2%, while December gold futures also declined. Currency markets were relatively subdued, with the EUR/USD pair seeing minimal change, while the US Dollar Index Futures posted a small loss.